Brigimadlin
Brigimadlin (BI 907828) is an orally active and highly potent E3 ubiquitin-protein ligase MDM2-p53 antagonist with antitumor activity.Brigimadlin can be used to study metastatic BTC, PDAC, lung adenocarcinoma, or bladder cancer.
Product Specifications
CAS Number
2095116-40-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
591.46
Molecular Formula
C31H25Cl2FN4O3
Notes
Research use only, not for human use.
Receptor
Mdm2 | p53
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog